Burlingame, CA, Aug. 28, 2025 (GLOBE NEWSWIRE) — The Global Cellular Immunotherapy Market is estimated to be valued at USD 7.64 Bn in 2025 and is expected to reach USD 20.45 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 15.1% from 2025 to 2032. This strong market growth is fueled by the rising adoption of personalized medicine, rapid advancements in gene editing technologies, and the increasing global incidence of cancer and autoimmune diseases. Additionally, a growing pipeline of innovative therapies and supportive regulatory environments are further enhancing the market’s outlook for the forecast period. Current trends reveal a notable shift toward the development of allogeneic and off-the-shelf cellular immunotherapies, which offer reduced manufacturing time and lower costs compared to traditional autologous approaches. Moreover, the integration of artificial intelligence and machine learning is gaining traction, helping to refine treatment protocols and improve patient selection.
Request Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/8447
Global Cellular Immunotherapy Market Key Takeaways
According to Coherent Market Insights (CMI), the global cellular immunotherapy market size is expected to grow nearly 2.7X during the forecast period, totaling USD 20.45 Bn by 2032, up from USD 7.64 Bn in 2025.
Global cellular immunotherapy demand is poised to rise at a CAGR of 15.1% between 2025 and 2032.
CAR T-cell therapy is anticipated to remain a highly sought-after therapy type, capturing a prominent market share of 45.2% by 2025.
Based on source, autologous segment is forecast to account for nearly three-fifths of the global cellular immunotherapy market share in 2025.
Cancer segment, with an estimated market share of 45.6% in 2025, is expected to dominate the target industry during the projection period.
North America is expected to remain the undisputed market leader, capturing nearly two-fifths of the global cellular immunotherapy industry share by 2025.
Asia Pacific is slated to emerge as a hotbed for cellular immunotherapy companies during the forecast period.
Increasing Incidence of Cancer and Chronic Diseases Spurring Market Growth
Coherent Market Insights’ new cellular immunotherapy market analysis outlines key factors driving industry growth. One such prominent growth driver is the rising prevalence of cancer and chronic diseases.
There is a spike in chronic conditions like cancer, autoimmune disorders, and infectious diseases globally. This is expected to fuel demand for cellular immunotherapies during the forthcoming period, as these conditions require advanced treatments.
International Agency for Research on Cancer (IARC) estimates that by 2050, more than 35 million new cancer cases will be diagnosed each year. This rising cancer incidence will likely create a conducive environment for the growth of cellular immunotherapy market.
Cellular immunotherapies, also known as adoptive cell therapies, are igniting a new ray of hope for patients with previously incurable diseases. They mostly use a patient’s own immune cells, such as T cells or natural killer (NK) cells, to fight diseases like cancer.
Purchase Now Up to 25% Discount on This Premium Report: https://www.coherentmarketinsights.com/insight/buy-now/8447
High Treatment Costs Hampering Cellular Immunotherapy Market Growth
The global cellular immunotherapy market outlook looks bright and exciting, owing to growing prevalence of chronic diseases and rising demand for advanced cell-based therapies. However, high cost of cellular immunotherapies remains a significant barrier to broader market growth.
Cellular immunotherapies, such as CAR T-cell therapy and TCR-T cell therapy, are very expensive because they involve complicated steps to extract, …